Arts therapies (ATs) for the treatment of autism spectrum disorders (ASD) has attracted widespread attention from scholars. However, resources, technical, and ethical issues still pose significant obstacles to current research. A collaborative design approach is needed to guide the intervention treatment process involving multiple stakeholders. Therefore, this study focuses on exploring the current status, development and potential value of the collaborative arts therapies (CATs), providing a comprehensive perspective for subsequent research. The Web of Science, PubMed, ScienceDirect, and Cochrane Library were searched for publications up to August 30, 2023, related to the use of CATs for the treatment of ASD. CiteSpace was used to build a knowledge graph to achieve visual analysis of current research countries, institutions, journals, authors, and hot topics. A total of 845 articles met the inclusion criteria. In terms of quantity, the USA is the leading country which has the greatest influence in advancing the field. The University of Haifa is the most productive institution. Arteterapia Papeles De Arteterapia Y Educacion Artistica and Frontiers in Psychology occupy key publishing positions. The most central keywords were related to the quality of life of people with ASD. “family”, “social robot” and “participation” are emerging topics in the research field. The positive impact of the combination of caregivers, technology and artistic media on enhancing connections between people with ASD and their everyday environment is the focus of current research. Research on CATs as an adjunctive therapy for the treatment of ASD is evolving. Providing comprehensive rehabilitation and support intervention for patients with ASD is a key research direction. The research process requires more interdisciplinary resources and technical assistance. Collaboration will be the best way to improve the effectiveness of ATs.
Introduction: Schizophrenia, a chronic mental problem, significantly impacts cognition, emotion and social functioning. Conventional pharmacotherapy faces challenges including numerous side effects, low adherence to medication and substantial costs. In this context, group arts therapies (GATs) emerge as a promising complementary approach for symptom alleviation in schizophrenia patients. Nonetheless, the effectiveness and safety of GATs are yet to be firmly established. This study aims to systematically assess the therapeutic impact of all group-based artistic interventions as complementary treatments for schizophrenia, focusing on their potential benefits. Methods and analysis: This study will search four English-language databases (PubMed, Web of Science, Cochrane Library and Embase), two Chinese databases (Wanfang Data and China National Knowledge Infrastructure) and three Korean databases (RISS, Korean Citation Index and DBpia) from their inception until October 2023. It will include all randomised controlled trials that compare GATs for schizophrenia with standard rehabilitation methods. The primary outcome is the improvement in patients’ positive and negative symptoms. Methodologies such as bias risk assessment, data synthesis, sensitivity analysis and subgroup analysis will be implemented using Review Manager V.5.4. Study results with high heterogeneity will be merged using a random-effects model ( I2 >50% or p<0.1). In cases where meta-analysis is not viable due to significant clinical and methodological heterogeneity, a qualitative summary of the findings will be provided. Ethics and dissemination: The data used in this systematic review are anonymised, devoid of any private information, eliminating the requirement for ethical approval. Dissemination of the research findings will be conducted via peer-reviewed publications. PROSPERO registration number: CRD42023471583.
While global ageing has heightened dementia prevalence, current treatments remain limited in efficacy and are burdened by side effects. Against this background, art therapy has gained attention as an innovative alternative intervention for dementia. For non-pharmacological dementia care, museums are inclusive cultural spaces offering safe and supportive environments. This review examines how Museum-Based Creative Arts Interventions (MCAIs) can alleviate dementia symptoms and evaluates their benefits. We searched six databases for studies meeting three criteria, that is, museum/gallery-based interventions, dementia-diagnosed participants, and creative arts interventions as the primary treatment. Among 1080 screened articles, 31 qualified studies were selected for inclusion. Overall, MCAIs help alleviate cognitive and emotional symptoms while enhancing the quality of life for people living with dementia by strengthening social connections, self-esteem, communication, and shared meaning. This review highlights the beneficial role of museums with art interventions in health. Findings can inform museum-health collaborations and cultural institutions’ public wellness strategies.